Showing results (1651-1660 of 2,014) with videos related to
Sort By:
Pageof 202
Critical Reviews in Oncology/Hematology|January 21, 2015
New perspectives in the treatment of adult medulloblastoma in the era of molecular oncologyAlba A Brandes, Marco Bartolotti, Gianluca Marucci, et al.Clinical Colorectal Cancer|April 15, 2019
A Genomic Analysis Workflow for Colorectal Cancer Precision OncologyGiorgio Corti, Alice Bartolini, Giovanni Crisafulli, et al.Pharmaceutics|August 29, 2024
Stepwise Structural Simplification of the Dihydroxyanthraquinone Moiety of a Multitarget Rhein-Based Anti-Alzheimer Lead to Improve Drug Metabolism and Pharmacokinetic PropertiesCaterina Pont, Anna Sampietro, F Javier Pérez-Areales, et al.Microorganisms|August 29, 2024
The Drug Susceptibility of Non-Tuberculous Mycobacteria (NTM) in a Referral Hospital in Rome from 2018 to 2023Antonio Mazzarelli, Carla Nisii, Angela Cannas, et al.AMB Express|February 19, 2020
Human bone morphogenetic protein-2 (hBMP-2) characterization by physical-chemical, immunological and biological assaysMiriam Fussae Suzuki, João Ezequiel Oliveira, Renata Damiani, et al.Breast Cancer Research : BCR|March 7, 2021
Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patientsLauren Darrigues, Jean-Yves Pierga, Alice Bernard-Tessier, et al.Scientific Reports|August 8, 2022
Alterations to the broad-spectrum formin inhibitor SMIFH2 modulate potency but not specificityMarina Orman, Maya Landis, Aisha Oza, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-Akt-positive or never smoker patients with advanced non-small-cell lung cancer: the ONCOBELL trialFederico Cappuzzo, Claudia Ligorio, Pasi A Jänne, et al.Journal of Neuro-Oncology|November 5, 2014
Post progression survival in glioblastoma: where are we?Enrico Franceschi, Mario Ermani, Stefania Bartolini, et al.Nature Biotechnology|August 13, 2002
Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarraysRenata Grifantini, Erika Bartolini, Alessandro Muzzi, et al.Pageof 202